These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


2196 related items for PubMed ID: 34471502

  • 1. The molecular feature of macrophages in tumor immune microenvironment of glioma patients.
    Zhang H, Luo YB, Wu W, Zhang L, Wang Z, Dai Z, Feng S, Cao H, Cheng Q, Liu Z.
    Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502
    [Abstract] [Full Text] [Related]

  • 2. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S, Li Y, Xu J, Shen L.
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [Abstract] [Full Text] [Related]

  • 3. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N, Zhu L, Wang L, Shen Z, Huang X.
    Comput Struct Biotechnol J; 2022 Mar; 20():3106-3119. PubMed ID: 35782736
    [Abstract] [Full Text] [Related]

  • 4. Identifies microtubule-binding protein CSPP1 as a novel cancer biomarker associated with ferroptosis and tumor microenvironment.
    Wang W, Zhang J, Wang Y, Xu Y, Zhang S.
    Comput Struct Biotechnol J; 2022 Mar; 20():3322-3335. PubMed ID: 35832625
    [Abstract] [Full Text] [Related]

  • 5. Violations of proportional hazard assumption in Cox regression model of transcriptomic data in TCGA pan-cancer cohorts.
    Zeng Z, Gao Y, Li J, Zhang G, Sun S, Wu Q, Gong Y, Xie C.
    Comput Struct Biotechnol J; 2022 Mar; 20():496-507. PubMed ID: 35070171
    [Abstract] [Full Text] [Related]

  • 6. PreMSIm: An R package for predicting microsatellite instability from the expression profiling of a gene panel in cancer.
    Li L, Feng Q, Wang X.
    Comput Struct Biotechnol J; 2020 Mar; 18():668-675. PubMed ID: 32257050
    [Abstract] [Full Text] [Related]

  • 7. Integrative omics analysis reveals relationships of genes with synthetic lethal interactions through a pan-cancer analysis.
    Guo L, Li S, Qian B, Wang Y, Duan R, Jiang W, Kang Y, Dou Y, Yang G, Shen L, Wang J, Liang T.
    Comput Struct Biotechnol J; 2020 Mar; 18():3243-3254. PubMed ID: 33240468
    [Abstract] [Full Text] [Related]

  • 8. Advancing Pan-cancer Gene Expression Survial Analysis by Inclusion of Non-coding RNA.
    Ye B, Shi J, Kang H, Oyebamiji O, Hill D, Yu H, Ness S, Ye F, Ping J, He J, Edwards J, Zhao YY, Guo Y.
    RNA Biol; 2020 Nov; 17(11):1666-1673. PubMed ID: 31607216
    [Abstract] [Full Text] [Related]

  • 9. Comprehensive analysis of tumor necrosis factor-α-inducible protein 8-like 2 (TIPE2): A potential novel pan-cancer immune checkpoint.
    Bai KH, Zhang YY, Li XP, Tian XP, Pan MM, Wang DW, Dai YJ.
    Comput Struct Biotechnol J; 2022 Nov; 20():5226-5234. PubMed ID: 36187930
    [Abstract] [Full Text] [Related]

  • 10. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X, Wang Y, A G, Qu C, Chen J.
    Front Immunol; 2021 Nov; 12():721030. PubMed ID: 34531868
    [Abstract] [Full Text] [Related]

  • 11. Rewired functional regulatory networks among miRNA isoforms (isomiRs) from let-7 and miR-10 gene families in cancer.
    Liang T, Han L, Guo L.
    Comput Struct Biotechnol J; 2020 Nov; 18():1238-1248. PubMed ID: 32542110
    [Abstract] [Full Text] [Related]

  • 12. Comprehensive analysis of the novel omicron receptor AXL in cancers.
    Zhang WN, Li XP, Wang PF, Zhu L, Xiao XH, Dai YJ.
    Comput Struct Biotechnol J; 2022 Nov; 20():3304-3312. PubMed ID: 35782741
    [Abstract] [Full Text] [Related]

  • 13. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
    Chang S, Yim S, Park H.
    Exp Mol Med; 2019 Jun 20; 51(6):1-17. PubMed ID: 31221981
    [Abstract] [Full Text] [Related]

  • 14. Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis.
    Gao ZW, Yang L, Liu C, Wang X, Guo WT, Zhang HZ, Dong K.
    Front Immunol; 2022 Jun 20; 13():903461. PubMed ID: 35663977
    [Abstract] [Full Text] [Related]

  • 15. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
    Guo B, Wang Y, Liu W, Zhang S.
    Clin Transl Oncol; 2023 Feb 20; 25(2):535-554. PubMed ID: 36255654
    [Abstract] [Full Text] [Related]

  • 16. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer].
    Zhang SY, Ruan JJ, Jin DM, Chen N, Xie WG, Ruan QF.
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun 20; 39(6):518-526. PubMed ID: 37805766
    [Abstract] [Full Text] [Related]

  • 17. The SARS-CoV-2 host cell receptor ACE2 correlates positively with immunotherapy response and is a potential protective factor for cancer progression.
    Zhang Z, Li L, Li M, Wang X.
    Comput Struct Biotechnol J; 2020 Jun 20; 18():2438-2444. PubMed ID: 32905022
    [Abstract] [Full Text] [Related]

  • 18. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S, Wei M, Wang S, Dong J, Wei J.
    Front Immunol; 2020 Jun 20; 11():1218. PubMed ID: 32714316
    [Abstract] [Full Text] [Related]

  • 19. Pan-cancer and single-cell analysis reveal dual roles of lymphocyte activation gene-3 (LAG3) in cancer immunity and prognosis.
    Wang Y, Zhao Y, Zhang G, Lin Y, Fan C, Wei H, Chen S, Guan L, Liu K, Yu S, Fu L, Zhang J, Yuan Y, He J, Cai H.
    Sci Rep; 2024 Oct 15; 14(1):24203. PubMed ID: 39406840
    [Abstract] [Full Text] [Related]

  • 20. Systematic pan-cancer analyses of the potential function of the Golgi scaffold protein PAQR3.
    Ling ZN, Hong LL, Wu J, Ling ZQ.
    Sci Rep; 2024 Feb 06; 14(1):3030. PubMed ID: 38321173
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 110.